Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-10.07	38.36	42.66
Graham Fair Price	177.72	9.51	3.42
PEG	-98.17	0.03	-1.40
Price/Book	-32.58	0.68	1.01
Price/Cash Flow	66.20	-93.98	-278.00
Prices/Earnings	-88.42	12.99	112.22
Price/Sales	-27.95	3.12	4.33
Price/FCF	66.20	-93.98	-278.00
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	9.56	0.50	0.46
Operating Margin	3001.43	0.10	< 0.005
ROA	489.39	< 0.005	< 0.005
ROE	< 0.005	0.01	482.40
ROIC	< 0.005	< 0.005	161.28
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.05	-88.67
Dividends QOQ	-0.78	0.04	-95.02
EBIT QOQ	-1.05	30.44	2792.16
EPS QOQ	-0.80	5.05	531.58
FCF QOQ	0.73	-1.02	39.67
Revenue QOQ	0.15	-0.05	-66.19
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	116.65	129.30	10.84
Days Sales Outstanding (DSO)	83.85	73.95	-11.80
Inventory Turnover	0.77	0.70	-9.78
Debt/Capitalization	0.43	0.43	-1.14
Quick Ratio	0.76	0.70	-8.12
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	15.19	17.48	15.08
Cash	5.18	5.67	9.35
Capex	-0.37	-0.47	-27.15
Free Cash Flow	-0.06	-0.13	-129.52
Revenue	3.56	3.83	7.69
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.00	1.01	0.60
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	13.49	15.68	16.25
Naive Interpretation	Member

06 - Financial Health · Bad

Rating